SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,572 Cr | ₹1,531 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,572 Cr |
| Mar2024 | ₹1,531 Cr |
| Mar2023 | ₹1,484 Cr |
| Mar2022 | ₹1,487 Cr |
| Mar2021 | ₹1,443 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,572 Cr | 2.68 | |
| Mar2024 | ₹1,531 Cr | 3.19 | |
| Mar2023 | ₹1,484 Cr | -0.19 | |
| Mar2022 | ₹1,487 Cr | 3.02 | |
| Mar2021 | ₹1,443 Cr | - | |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,126.8 Cr | -0.1% | 6.7% | 58% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -0.1% |
6.7% |
58% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses